NM_001316349.2(THSD7B):c.832A>G (p.Thr278Ala) AND not specified

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Apr 22, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004668633.1

Allele description [Variation Report for NM_001316349.2(THSD7B):c.832A>G (p.Thr278Ala)]

NM_001316349.2(THSD7B):c.832A>G (p.Thr278Ala)

Gene:

THSD7B:thrombospondin type 1 domain containing 7B [Gene - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

2q22.1

Genomic location:

Preferred name:

NM_001316349.2(THSD7B):c.832A>G (p.Thr278Ala)

Other names:

NM_001080427.1:c.739A>G

HGVS:

NC_000002.12:g.137057112A>G
NM_001316349.2:c.832A>GMANE SELECT
NP_001303278.1:p.Thr278Ala
NC_000002.11:g.137814682A>G

Protein change:

T278A

Molecular consequence:

NM_001316349.2:c.832A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Explanation of Levels of Evidence of Carcinogenic Activity - NTP Technical Repor...
Explanation of Levels of Evidence of Carcinogenic Activity - NTP Technical Report on the Toxicology and Carcinogenesis Studies of Di(2-ethylhexyl) Phthalate (CASRN 117-81-7) Administered in Feed to Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats
ABC transporter G family member 21-like isoform X1 [Benincasa hispida]
ABC transporter G family member 21-like isoform X1 [Benincasa hispida]
gi|1955840336|ref|XP_038876290.1|

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV005171063	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Apr 22, 2024)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV005171063

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Apr 22, 2024)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV005171063.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The c.739A>G (p.T247A) alteration is located in exon 2 (coding exon 2) of the THSD7B gene. This alteration results from a A to G substitution at nucleotide position 739, causing the threonine (T) at amino acid position 247 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Aug 11, 2024

ClinVar

Relating variation to medicine